NTRBNutriBand Inc.

Nasdaq nutriband.com


$ 3.36 $ 0.00 (0 %)    

Friday, 10-May-2024 12:16:58 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 3.36
$ 3.37
$ 0.00 x 0
$ 0.00 x 0
$ 3.36 - $ 3.37
$ 1.53 - $ 5.93
12,178
na
36.86M
$ 2.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 01-31-2024 10-K
2 12-13-2023 10-31-2023 10-Q
3 09-08-2023 01-01-1970 10-Q
4 06-09-2023 04-30-2023 10-Q
5 04-26-2023 01-31-2023 10-K
6 12-02-2022 10-31-2022 10-Q
7 09-07-2022 07-31-2022 10-Q
8 05-31-2022 04-30-2022 10-Q
9 04-28-2022 01-31-2022 10-K
10 12-14-2021 10-31-2021 10-Q
11 09-03-2021 07-31-2021 10-Q
12 06-14-2021 04-30-2021 10-Q
13 04-02-2021 01-31-2021 10-K
14 12-15-2020 10-31-2020 10-Q
15 09-11-2020 07-31-2020 10-Q
16 06-04-2020 04-30-2020 10-Q
17 04-14-2020 01-31-2020 10-K
18 12-12-2019 10-31-2019 10-Q
19 09-13-2019 07-31-2019 10-Q
20 06-13-2019 04-30-2019 10-Q
21 04-19-2019 01-31-2019 10-K
22 12-14-2018 10-31-2018 10-Q
23 09-17-2018 07-31-2018 10-Q
24 06-18-2018 04-30-2018 10-Q
25 05-01-2018 01-31-2018 10-K
26 12-08-2017 10-31-2017 10-Q
27 09-19-2017 07-31-2017 10-Q
28 06-19-2017 04-30-2017 10-Q
29 05-08-2017 01-31-2017 10-K
30 12-13-2016 10-31-2016 10-Q
31 09-14-2016 07-31-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nutriband-discloses-84m-private-placement-representing-210m-shares-of-common-stock-at-4-per-share-company-targets-505b2-nda-to-fda-for-marketing-approval-of-aversa-fentanyl-in-q1-2025

Company says that for each Share of common stock purchased the investor receives a five-year warrant to purchase two shares of ...

 why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

 why-luxurban-hotels-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fo...

 nutriband-provided-an-overview-of-the-clinical-development-and-regulatory-pathway-for-its-lead-product-aversa-fentanyl-an-abuse-deterrent-fentanyl-transdermal-patch

NDA will be primarily based on a single Phase 1 human abuse potential clinical study with no Phase 2 or 3 clinical trials neede...

Core News & Articles

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, today ...

 nutriband-q2-eps-011-up-from-012-yoy-sales-65593k-up-from-45615k-yoy

Nutriband (NASDAQ:NTRB) reported quarterly losses of $(0.11) per share. This is a 8.33 percent increase over losses of $(0.12) ...

 why-state-street-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 millio...

Core News & Articles

https://nutriband.com/news/nutriband-increases-existing-credit-line-to-5-million-usd-supporting-the-continued-development-of-it...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION